Integra LifeSciences Holdings Corporation (IART)

NasdaqGS Currently down 0.26 (-1.38%) in today's trading session

2 members of Congress have disclosed 4 trades in Integra LifeSciences Holdings Corporation (IART) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 16 October 2020. The most active traders have been Josh Gottheimer (3) and Gilbert Cisneros (1). Aggregate disclosed activity totals roughly $24K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Integra LifeSciences Holdings Corporation is currently trading at $18.56, positioned at 85% of its 52-week range ($8.70 – $20.26).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$18.56
24h Change
-0.26 (-1.38%)
52 Week Range
$8.70$20.26
View on NASDAQ

Integra LifeSciences Holdings Corporation Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for IART

Select to highlight on chart
4 transactions
Compliance: 100%
Josh Gottheimer16 Oct 20205 Nov 2020PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer15 Sept 202013 Oct 2020SaleStock$1,001 - $15,000N/A
Gilbert Cisneros10 Feb 202010 Mar 2020PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer3 Feb 202016 Mar 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.44B

Volume

603.77K

Beta

1.22

P/E Ratio

7.86

Fundamentals

EPS

$2.36

Div. Yield

Open

$18.55

Day Range

$18.29 — $18.86

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ · USD
Country
US
CEO
Stuart Essig
IPO Date
1995-08-16

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including...

Earnings

Next Report

Q2 2026

29 Jul

EPS Est.

$0.48

Rev. Est.

$417.6M

Days Until

6

Recent Quarters

Q1 20265 May
EPS$0.54
Beat 31.7%
Q4 202526 Feb
EPS$0.83
Beat 5.1%
Q3 202530 Oct
EPS$0.54
Beat 25.6%
Q2 202531 Jul
EPS$0.45
Beat 4.7%
Q1 20255 May
EPS$0.41
Miss 4.7%
Q4 202425 Feb
EPS$0.97
Beat 12.8%
Q3 20244 Nov
EPS$0.41
Beat 5.1%
Q2 202429 Jul
EPS$0.63
Beat 1.6%
Q1 20246 May
EPS$0.55
Beat 0.0%
Q4 202328 Feb
EPS$0.89
Miss 1.1%
Q3 202325 Oct
EPS$0.76
Miss 2.6%
Q2 202326 Jul
EPS$0.71
Beat 24.6%
Q1 202326 Apr
EPS$0.74
Beat 0.0%
Q4 202222 Feb
EPS$0.94
Beat 1.1%
Q3 202226 Oct
EPS$0.86
Beat 19.4%
Q2 202227 Jul
EPS$0.82
Beat 2.5%
Q1 202227 Apr
EPS$0.74
Beat 8.8%
Q4 202123 Feb
EPS$0.84
Beat 1.2%
Q3 20212 Nov
EPS$0.86
Beat 19.4%
Q2 202128 Jul
EPS$0.79
Beat 17.9%
Q1 202128 Apr
EPS$0.69
Beat 21.1%
Q4 202018 Feb
EPS$0.84
Beat 15.1%
Q3 202028 Oct
EPS$0.80
Beat 40.4%
Q2 202010 Aug
EPS$0.33
Beat 312.5%
Q1 20207 May
EPS$0.48
Miss 20.0%
Q4 201919 Feb
EPS$0.68
Beat 1.5%
Q3 201924 Oct
EPS$0.68
Beat 4.6%
Q2 201924 Jul
EPS$0.73
Beat 12.3%
Q1 201924 Apr
EPS$0.65
Beat 6.6%
Q4 201821 Feb
EPS$0.65
Beat 4.8%
Q3 201831 Oct
EPS$0.59
Beat 0.0%
Q2 201825 Jul
EPS$0.60
Beat 0.0%
Q1 201825 Apr
EPS$0.58
Beat 18.4%
Q4 201727 Feb
EPS$0.64
Beat 14.3%
Q3 201726 Oct
EPS$0.45
Miss 4.3%
Q2 201726 Jul
EPS$0.45
Beat 0.0%
Q1 201726 Apr
EPS$0.39
Miss 2.5%
Q4 201623 Feb
EPS$0.52
Beat 0.0%
Q3 201627 Oct
EPS$0.47
Beat 6.8%
Q2 201628 Jul
EPS$0.40
Beat 5.3%
Q1 201627 Apr
EPS$0.37
Beat 0.0%
Q4 201525 Feb
EPS$0.44
Beat 2.3%
Q3 20153 Nov
EPS$0.38
Beat 2.7%
Q2 201530 Jul
EPS$0.40
Beat 8.1%
Q1 201530 Apr
EPS$0.38
Beat 18.8%
Q4 201424 Feb
EPS$0.47
Beat 4.4%
Q3 20143 Nov
EPS$0.38
Beat 2.7%
Q2 20145 Aug
EPS$0.34
Beat 6.3%
Q1 20141 May
EPS$0.29
Beat 0.0%
Q4 201325 Feb
EPS$0.39
Miss 4.9%
Q3 201328 Oct
EPS$0.36
Beat 2.9%
Q2 20131 Aug
EPS$0.30
Beat 7.1%
Q1 20132 May
EPS$0.20
Miss 16.7%
Q4 201221 Feb
EPS$0.39
Beat 0.0%
Q3 201224 Oct
EPS$0.43
Beat 13.2%
Q2 201226 Jul
EPS$0.37
Beat 8.8%
Q1 201225 Apr
EPS$0.36
Beat 20.0%
Q4 201123 Feb
EPS$0.36
Beat 12.5%
Q3 201131 Oct
EPS$0.39
Beat 2.6%
Q2 201128 Jul
EPS$0.35
Beat 2.9%
Q1 201128 Apr
EPS$0.33
Beat 0.0%
Q4 201024 Feb
EPS$0.40
Beat 8.1%
Q3 201028 Oct
EPS$0.37
Beat 12.1%
Q2 201029 Jul
EPS$0.34
Beat 6.3%
Q1 20103 May
EPS$0.32
Beat 14.3%
Q4 20091 Mar
EPS$0.30
Beat 3.5%
Q3 20094 Nov
EPS$0.27
Beat 3.9%
Q2 20096 Aug
EPS$0.26
Beat 8.3%
Q1 20096 May
EPS$0.24
Beat 4.3%
Q4 20082 Mar
EPS$0.27
Miss 3.6%
Q3 20087 Nov
EPS$0.23
Beat 0.0%
Q2 200811 Aug
EPS$0.25
Beat 8.7%
Q1 20084 Jun
EPS$0.25
Beat 25.0%
Q1 200816 May
EPS$0.27
Beat 8.0%
Q3 20079 Nov
EPS$0.20
Miss 9.1%
Q2 20077 Aug
EPS$0.21
Beat 16.7%
Q1 20079 May
EPS$0.17
Beat 0.0%
Q4 200628 Feb
EPS$0.21
Beat 0.0%
Q3 20062 Nov
EPS$0.18
Beat 5.9%
Q2 20062 Aug
EPS$0.17
Beat 6.3%
Q1 20068 May
EPS$0.16
Beat 14.3%
Q4 20055 Mar
EPS$0.19
Beat 0.0%
Q3 200530 Oct
EPS$0.18
Beat 5.9%
Q2 20057 Aug
EPS$0.14
Beat 0.0%
Q1 20058 May
EPS$0.14
Miss 6.7%
Q4 200413 Mar
EPS$0.15
Beat 7.1%
Q3 20047 Nov
EPS$0.14
Beat 0.0%
Q2 200427 Jul
EPS$0.12
Miss 7.7%
Q1 200427 Apr
EPS$0.12
Beat 0.0%
Q4 200327 Feb
EPS$0.15
Beat 0.0%
Q3 200331 Oct
EPS$0.12
Beat 33.3%
Q2 200331 Jul
EPS$0.09
Beat 0.0%
Q1 200325 Apr
EPS$0.09
Beat 12.5%
Q4 200227 Feb
EPS$0.08
Beat 0.0%
Q3 20024 Nov
EPS$0.07
Beat 0.0%
Q2 20021 Aug
EPS$0.07
Beat 16.7%
Q1 20028 May
EPS$0.07
Beat 16.7%
Q4 200127 Feb
EPS$0.06
Beat 20.0%
Q3 20017 Nov
EPS$0.07
Beat 46.5%
Q2 20012 Aug
EPS$0.04
Beat 21.2%
Q1 20019 May
EPS$0.04
Beat 20.0%
Q4 200028 Feb
EPS$0.03
Beat 140.0%
Q3 20008 Nov
EPS$0.02
Beat 243.1%
Q2 200010 Aug
EPS$-0.02
Beat 71.4%
Q1 20005 May
EPS$-0.03
Beat 40.0%
Q4 19992 Mar
EPS$-0.02
Beat 60.0%
Q3 19999 Nov
EPS$-0.06
Beat 25.0%
Q2 19995 Aug
EPS$-0.08
Beat 46.7%
Q1 199914 May
EPS$-0.10
Miss 42.9%
Q4 19983 Mar
EPS$-0.08
Beat 11.1%
Q3 199813 Nov
EPS$-0.09
Beat 10.0%
Q2 19985 Aug
EPS$-0.10
Beat 16.7%
Q1 19986 May
EPS$-0.10
Beat 0.0%
Q4 19973 Mar
EPS$-0.12
Miss 20.0%
Q3 199713 Nov
EPS$-0.08
Miss 14.3%
Q2 19975 Aug
EPS$-0.07
Miss 40.0%
Q1 19975 May
EPS$-0.06
Beat 14.3%
Q4 19963 Mar
EPS$-0.08
Miss 220.0%
Q3 199614 Nov
EPS$-0.07
Q3 19964 Nov
EPS$-0.07
Miss 75.0%
Q1 19961 May
EPS$-0.06
Beat 25.0%
Q4 19956 Mar
EPS$-0.09
Miss 28.6%
Q3 199515 Nov
EPS$-0.06
Beat 0.0%
Q2 199530 Sept
EPS$-0.97
Q4 199431 Mar
EPS$-0.09

2 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

4 Jan 2017Stock Split
Ratio2:1
1 Jul 2015Stock Split
Ratio553:500
26 May 1998Reverse Split
Ratio1:2

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LLY

Eli Lilly and Company

74
$1185.87+22.86 (+1.97%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

JNJ

Johnson & Johnson

74
$259.27+3.64 (+1.42%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

MSFT

Microsoft Corporation

69
$381.58-8.76 (-2.24%)
Technology
2 politicians both hold this
$24M in total holdings
2 politicians
View Stock

Frequently Asked Questions about IART

Which members of Congress have traded IART?
2 members of Congress have disclosed 4 trades in Integra LifeSciences Holdings Corporation (IART) under the STOCK Act. The most active traders are Josh Gottheimer and Gilbert Cisneros.
When was IART most recently disclosed by Congress?
The most recent IART disclosure was a purchase by Josh Gottheimer on 16 October 2020.
What is the total disclosed congressional trading volume for IART?
Members of Congress have disclosed approximately $24K in IART purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in IART?
This IART page updates as soon as new STOCK Act disclosures are filed for Integra LifeSciences Holdings Corporation. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.